Salmon Nasal Cartilage-Derived Proteoglycans Alleviate Monosodium Iodoacetate-Induced Osteoarthritis in Rats
Marine Drugs · 2024
DOI: 10.3390/md22110507 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von Inae Jeong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Food and Nutrition, Chonnam National University, Gwangju 61186, Republic of Korea. Hauptthemen laut MEDLINE: Proteoglycans, Osteoarthritis, Apoptosis, Nasal Cartilages. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Osteoarthritis is a chronic inflammatory condition characterized by the degeneration of joint cartilage and underlying bone, resulting in pain, swelling, and reduced mobility. This study evaluates the efficacy of salmon nasal cartilage-derived proteoglycans in mitigating osteoarthritis symptoms and investigates the underlying molecular mechanisms. This study employed a rat model of osteoarthritis induced by monosodium iodoacetate (MIA) injection. The rats were orally administered salmon nasal cartilage-derived proteoglycans or ibuprofen. Key aspects of osteoarthritis pathology, including impaired exercise ability, inflammation, extracellular matrix degradation, and chondrocyte apoptosis, were assessed using histological analysis, micro-CT, treadmill testing, serum assays, and mRNA/protein expression studies. The MIA injection caused significant cartilage damage, reduced bone mineral density, and impaired exercise ability. Additionally, it elevated serum levels of prostaglandin E2 and nitric oxide, increased the mRNA and protein levels of inflammation-related factors, and activated apoptosis signaling pathways in cartilage. Treatment with salmon nasal cartilage-derived proteoglycans significantly improved cartilage morphology and mineralization, reduced inflammation, and inhibited apoptosis signaling pathways, with effects comparable to those observed with ibuprofen treatment. These findings highlight the potential of salmon nasal cartilage-derived proteoglycans as a therapeutic agent for managing osteoarthritis by effectively reducing inflammation, preventing cartilage degradation, and inhibiting chondrocyte apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Food and Nutrition, Chonnam National University, Gwangju 61186, Republic of Korea.
- Nihon Pharmaceutical Co., Ltd., Tokyo 103-0012, Japan.
- Daedeok Pharma Co., Ltd., Suwon-si 16226, Republic of Korea.
- Human Ecology Research Institute, Chonnam National University, Gwangju 61186, Republic of Korea.
ORCID-Profile: Inae Jeong, Ok-Kyung Kim
Zitieren
APA
Jeong, I., Park, J., Park, S., Wada, T., Lim, D. S., & Kim, O. K. (2024). Salmon Nasal Cartilage-Derived Proteoglycans Alleviate Monosodium Iodoacetate-Induced Osteoarthritis in Rats. Marine Drugs. https://doi.org/10.3390/md22110507
Vancouver
Jeong I, Park J, Park S, Wada T, Lim DS, Kim OK. Salmon Nasal Cartilage-Derived Proteoglycans Alleviate Monosodium Iodoacetate-Induced Osteoarthritis in Rats. Marine Drugs. 2024. doi:10.3390/md22110507
BibTeX
@article{Jeong2024,
author = {Jeong, Inae and Park, Jinbum and Park, Shinjung and Wada, Tatuya and Lim, Dae Soo and Kim, Ok-Kyung},
title = {Salmon Nasal Cartilage-Derived Proteoglycans Alleviate Monosodium Iodoacetate-Induced Osteoarthritis in Rats},
journal = {Marine Drugs},
year = {2024},
doi = {10.3390/md22110507}
}
EUVIMED